SMAD4 and colonic neoplasm: This hypothesis can be supported by a chemical screening using isogenic BxPC-3 cell lines with, or without, SMAD4 gene deletion, in which a small-molecule UA62784 is identified as a selectively cytotoxic agent to kill SMAD4-deficient pancreatic and colon cancer cells [44].